Clinical Trials Directory

Trials / Completed

CompletedNCT01662622

Minimal Alveolar Concentration of Sevoflurane Inducing Isoelectric Electroencephalogram

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
31 (actual)
Sponsor
Huazhong University of Science and Technology · Academic / Other
Sex
All
Age
45 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Sevoflurane can abolish movement or adrenergic response to noxious stimulus. In order to investigate the effect of sevoflurane on cerebral electrical activity, we determined the MAC of sevoflurane inducing isoelectric electroencephalogram (EEG) in 50% of the subjects (MACie) in middle aged subjects.

Detailed description

Patients received sevoflurane for anesthesia induction and maintenance at preselected concentrations according to an 'up and down' design, with 0.2% as a stepsize. General anesthesia was induced and maintained with sevoflurane, tracheal intubation was facilitated with cisatracurium. After a steady-state period of 30min without surgical stimulation, the state of isoelectric EEG was considered as significant when a burst suppression ratio of 100% last for more than 1 min. The haemodynamic responses to skin incision and the vasopressor requirement to maintain cardiovascular system were also analysed according to the EEG state.

Conditions

Interventions

TypeNameDescription
DRUGSevofluraneThe design of experiment is referred to the "Dixon up-and-down" method. The first subject was designed to receive end-tidal sevoflurane concentration of 1.7%. For each subject, 30 min interval time was given. The isoelectric EEG was considered as significant when the isoelectric state last for more than 1min. The maximal burst suppression rate was recorded if isoelectric EEG was not reached. Heart rate and MAP, were recorded 2 and 1min before and 3 min after skin incision. Adrenergic reflexes positive cases were counted.

Timeline

Start date
2012-03-01
Primary completion
2012-05-01
Completion
2012-07-01
First posted
2012-08-10
Last updated
2012-08-14

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT01662622. Inclusion in this directory is not an endorsement.